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Distribution of genetic polymorphisms of EGR3 gene in healthy Uygur and
Chinese Han population in Xinjiang
Li Xia1,2, Ma Yi-tong1,2
1Department of Cardiology, First Afﬁliated Hospital of Xinjiang Medical University,
Urumqi, People’s Republic of China, 2Xinjiang Key Laboratory of Cardiovascular
Disease Research, Urumqi, People’s Republic of China
Objectives: To investigate the genetic polymorphisms of rs1008949 and rs1996147 of
EGR3 gene in healthy Chinese Han and Uygur population of Xinjiang.
Methods: The genotypes of the EGR3 gene were detected in 303 Uygur and 351 Han
healthy individuals using the TaqMan SNP genotyping assay.
Results: The genotype distributions of both populations were in the Hardy-Weinberg
equilibrium (P>0.05). The frequencies of CC,CT and TT genotypes of the rs1008949
locus were 34.3%,50.2%,and 15.5% in the Uygurs, and 28.2%,49.3%and 22.5% in the
Han participants. There was signiﬁcant difference in distribution of genotypes be-
tween the two populations (P<0.001). The frequencies of AA, AG and GG genotypes
of the rs1996147 locus were 24.7%, 51.5%, and 23.8% in Uygur participants, and
14.0%, 44.4%and 41.6%in Han participants. There was also signiﬁcant difference in
distribution of genotypes between the two populations (P<0.001).
Conclusions: The mutational frequencies of the tagging SNPs in rs1008949 and
rs1996147 loci of the EGR3 gene were signiﬁcantly different between Uygur and Han
populations.
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Evaluation anti-atrial ﬁbrillation drug model of multi-ion channels as a target
with micro-electrode chip technology
Sun Juan1,2,3, Huang Yan2, Ma Yi-Tong1,3
1Xinjiang Medical University, XingJiang, Urumqi, 2HuaDong hospital afﬁliated to
FuDan University, ShangHai, 3Cardiovascular Center, First afﬁliated hospital of
Xinjiang Medical University, XingJiang, Urumqi
Objectives: To screen and evaluate effection of anti-atrial ﬁbrillation drug on rapid
atrial pacin rabbit model with microelectrode arrays (MEA).
Methods: 32 rabbits were randomely divided into 4 groups: TEA group (n¼8), BaCl2
group (n ¼8), CdCl2 group (n ¼8), Amiodarone group (n¼8). The electrode was
inserted into right atrium via internal jugular vein with rapid right atrial pacing
(600 beat/min). effection of anti-atrial ﬁbrillation drug on ion channels were observed
after giving drugs (TEA, BaCl2, CdCl2 and Amiodarone).
Results: ﬁeld action potential (fAPD) prolonged in TEA group and BaCl2 group
(control vs blocker: 176.678.66 ms vs 196.1110.76 ms, 182.2212.87 ms vs
191.1113.09 ms, respectively, P<0.05). fAPD prolonged in CdCl2 group (control vs
blocker: 176.678.66ms vs 196.1110.76ms) (P<0.05). fAPD obviously extended
in Amiodarone group (control vs Amiodarone: 167.3813.67ms 18515.14ms,
P<0.01).
Conclusions: Atrial ﬁbrillation induced by rapid atrial pacing is a stable and reliable
Anti-arrhythmic drug therapy for atrial ﬁbrillation screening model on rabbit, It can be
used for anti-atrial ﬁbrillation drug development at early the rapid screening combines
with microelectrode chip technology.
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Association of Intercellular Adhesion Molecule-1 Gene Polymorphism with
Coronary Heart Disease in Han population in Xinjiang, China
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Objectives: Intercellular adhesion molecule-1 is an important adhesion molecule that
plays a crucial role in lymphocyte migration and in atherosclerosis pathogenesis
activation. The aim of the present study was to explore the association between the
rs5498 polymorphism of the ICAM-1 Gene and coronary heart disease (CHD) in Han
population in Xinjiang, China.
Methods: rs5498 polymorphism of ICAM-1 gene was detected with method of
polymerase chain reaction-restricted fragments length polymorphism in 674 CHD
patients and 779 control subjects.
Results: For total, the frequency of G allele was signiﬁcantly higher in CHD
patients than that in controls (29.2% vs. 23.3%, P<0.001). The frequency of
AG+GG genotypes was higher in patients with CHD than that in controls (49.7%
vs. 40.8%, P¼0.001). Multiple logistic regression analysis showed AG+GG was an
independent risk factor for CHD (OR¼1.919, 95%CI: 1.471-2.503, P<0.001). For
men, the frequencies of G allele and AG+GG genotype were also higher in CHD
patients than those in control subjects (29.9% vs. 22.7%, P<0.001 for frequency of
G allele; 50.6% vs. 40.3%, P¼0.001 for AG+GG genotype). For women, we didn’t
observe any signiﬁcant difference in genotype or allele distribution between the two
groups.
Conclusions: In the present study, rs5498 polymorphism of ICAM-1 gene was
associated with CHD in men of Chinese Han population. Men with G allele (AG and
GG genotype) might have higher risk for CHD than those with AA genotype.C24 JACC Vol 64/16/Suppl C j OctobGW25-e3503
OSM induced cardiomyocyte dedifferentiation regulates the progression of
diabetic cardiomyopathy through B-Raf/MeK/Erk signaling pathway
Zhang Xiaotian1,2, Sun Dongdong1, Chen Yundai2, Cao Feng2,1
1Cardiology Department, Xijing Hospital, 2Cardiology Department, Chinese PLA
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Objectives: It has been reported that oncostatin M (OSM) could initiate car-
diomyocyte dedifferentiation both in vivo and in vitro. OSM-induced cardiomyocyte
dedifferentiation might be a new target for the treatment of diabetic cardiomyopathy
(DCM). This study was designed to determine the role of OSM in cardiomyocyte
dedifferentiation and the progression of DCM.
Methods: Mouse DCM model were established to evaluate the effects of OSM in vivo
by injection of STZ for 5 consecutive days and random blood glucose value of
 16.7mmol/L was considered as a cutoff point for diabetes. Transthoracic echocar-
diography was applied to determine cardiac function. Immunoﬂuorescence staining
was used to detected dedifferentiation markers such as Runx1 and ANP. Sirus red
staining was used to detect ﬁbrosis area and Transmission electron microscopy (TEM)
was used to evaluate mitochondria impairment. Real Time PCR and Western blot were
performed to detect relative mRNA expression and the expressions of cardiomyocytes
dedifferentiation related proteins such as c-kit, scal-1, a-SM-actin, Runx1 and ANP.
Results: DCM mice exhibited multiple functional and structural changes in car-
diomyocytes and OSM treatment induced similar biological changes as those detected
in DCM mice. LVEF (49.253.75% vs. 70.074.37%, P<0.05) and FS (28.20
3.30% vs. 38.025.66%, P<0.05) were decreased, while LVEDV (87.187.47mL
vs. 75.508.23mL, P<0.05) and LVESV (40.092.99mL vs. 22.154.32mL, P<0.05)
were increased by OSM treatment as compared with the saline treated group. OSM
administration increased cardiac ﬁbrosis area (4.030.53% vs. 1.110.44%, P<0.05)
and aggravated mitochondria impairment as compared with control mice. Immuno-
ﬂuorescence staining showed OSM administration also signiﬁcantly up-regulated the
expressions of dedifferentiation makers Runx1 and ANP. Real-time PCR detected the
mRNA expression of OSM, Ob, c-kit, Runx1 and ANP were increased in OSM treated
mice compared with control mice and Western blot revealed the protein expression of
dedifferentiation makers (Runx1, a-SM-actin and ANP), typical fetal genes (c-kit, scal-
1) were increased in OSM treated mice compared with control mice. OSM recepror Ob
KO mice were used and B-Raf, Mek, P-Erk and total-Erk expressions were detected by
Western blot, indicating the mechanism of OSM induced cardiomyocyte dedifferen-
tiation was associated with B-Raf/Mek/Erk signaling pathway through Ob receptor.
Conclusions: We provided direct evidence that OSM played a crucial role in the
progression of diabetic cardiomyopathy through inducing cardiomyocyte dedifferen-
tiation. The mechanism of OSM induced cardiomyocyte dedifferentiation was asso-
ciated, at least in part, with B-Raf/Mek/Erk signaling pathway. The ﬁndings of the
present study might provide a new therapeutic molecular target for the further treat-
ment of diabetic cardiomyopathy.
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Resveratrol Alleviates Diabetic Cardiomyopathy through Improvement of
Mitochondrial Biogenesis and Function in a SIRT1-dependent Manner
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Objectives: Diabetic cardiomyopath (DCM) is associated with impaired mitochon-
drial biogenesis and function. Resveratrol, an activator of SIRT1, has been reported to
increase mitochondrial mass. Our study was designed to investigate whether resver-
atrol is capable of protecting against DCM via mitochondrial regulation.
Methods: Cardiac-speciﬁc SIRT1 KO mice (SIRT1CKO) were generated with SIRT1-
ﬂoxp+/+ and Myh6-Cre transgenic mice. Mice model were divided into six groups:
control group, DCM group, DCM+ Resveratrol group (DCM+ RES), SIRT1CKO
group, SIRT1CKO+ DCM group (SIRT1CKO+ DCM) and SIRT1CKO+ DCM+
Resveratrol group (SIRT1CKO+ DCM +R). DCM mice were injected with strepto-
zotoin. Resveratrol was added at the dose of 25 mg/kg/day for two months. Echo-
cardiography, HE, Masson trichrome, Sirus red staining and transmission electron
microscope were applied to reveal heart function, remodeling and mitochondrial
morphology. Cardiomyocyte apoptosis was assessed with TUNEL. In vitro H9c2 cell
study included six groups: control group, high glucose treated group (HG), HG+
Resveratrol group (HG+ RES), sh-SIRT1 group, sh-SIRT1+ HG group (sh-SIRT1+
HG) and sh-SIRT1+ HG+ Resveratrol group (sh-SIRT1+ HG+ R). Mitochondrial
function was evaluated by ATP generation, membrane potential (TFRM ﬂuorescence)
and citrate synthase activity. Mitochondrial biogenesis was analyzed with mtDNA
copy number. Immunoprecipitation was done to reveal the acetylation of SIRT1 tar-
geted PGC-1a. mRNA and protein expression of PGC-1a downstream genes (NRF-1,
NRF-2, ERR-a and TFAM) were analyzed with Real-time PCR and Western blot.
Results: SIRT1 expression was nearly undetectable in heart tissue of SIRT1CKO. As
compared with WT mice, DCM mice showed reduced cardiac function, damaged
cardiac ultrastructure and remodeling, accompanied with increased cardiomyocyte
apoptosis, decreased ATP generation and mtDNA amount (P<0.05), indicating
impaired mitochondrial function and biogenesis. DCM mice showed reduced SIRT1
expression in heart tissue. Resveratrol reversed these changes in DCM mice, but not in
DCM+ SIRT1CKO mice. In vitro results revealed that HG increased cell apoptosis as
compared with control group (P<0.05). Moreover, HG reduced mitochondrial
biogenesis and function in cardiomyocytes, evidenced by decreased ATP generation,er 16–19, 2014 j GW-ICC Abstracts/Basic and Translational Medicine
membrane potential, citrate synthase activity and mtDNA copy number (P<0.05).
Furthermore, HG cells showed decreased SIRT1 expression and PGC-1a acetylation.
Additionally, mRNA and protein expression of PGC-1a downstream genes (NRF-1,
NRF-2, ERR-a and TFAM) were reduced in HG group. Resveratrol reversed these
changes in HG group, but this effect was diminished in HG+ sh-SIRT1 group.
Conclusions: Resveratrol protects against cardiac apoptosis and improves cardiac
function in diabetic mice through enhancing mitochondrial biogenesis and function.
SIRT1 plays an important role in the resveratrol beneﬁcial effects against diabetic
cardiomyopathy.
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Ghrelin receptor deﬁciency aggravates instability of atherosclerotic plaque and
vascular inﬂammation in low-density lipoprotein receptor-null mice
Zhang Min, Xinkai Qu, Yiqing Yang, Lei Xu, Jinjie Dai, Weiyi Fang
Department of Cardiology, Shanghai ChestHospital, Shanghai Jiaotong University,
Shanghai, 200030, China
Objectives: Ghrelin has been found to be associated with anti-inﬂammation, inhibi-
tion of atherosclerotic plaque formation and plaque stability in cardiovascular system.
We investigated whether ghrelin affected the atherosclerotic plaque and immune
inﬂammation of atherosclerosis.
Methods: We crossed ghrelin receptor knock out mice (GHSR-/-) into a low-density
lipoprotein receptor-null (LDLR-/-) mouse line. In this model, atherosclerotic lesions
were promoted by feeding a high-fat, high-cholesterol Western-type diet for 18 weeks,
following a standard protocol. Serum lipid levels, atherosclerotic plaque on aortic
arches, and the expression of ICAM-1 and VCAM-1, T cell, macrophage and smooth
muscle cell of atherosclerotic plaque were observed.
Results: Though the serum lipid levels and atherosclerotic plaque area on aortic arches
were not signiﬁcantly different between in GHSR+/+/LDLR-/- mice and GHSR
-/-LDLR-/- mice, the protein expression of ICAM-1 and VCAM-1 in atherosclerosis
plaque were increased in GHSR -/-LDLR-/- mice than that in GHSR+/+/LDLR-/- mice.
T cell and macrophage were more, while the smooth muscle cells of atherosclerosis
plaque were less in GHSR -/-LDLR-/- mice than that in GHSR+/+/LDLR-/- mice.
Conclusions: In conclusion, ghrelin receptor deﬁciency aggravates instability of
atherosclerotic plaque and vascular inﬂammation but not atherosclerotic plaque area,
which will provide novel avenues for the treatment of atherosclerosis patients.
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Study on the relationship between the serum level of GDF15a and infarction area
for rats with myocardial infarction
Bin Wang1, Xia Yu2, Guodong Liang1
1Jilin Tumor Hospital, 2the First Hospital of Jilin University
Objectives: Through detecting the serum level of growth differentiation factor 15a
(GDF 15a) of the rats with different myocardial infarction area, to explore the rela-
tionship between the serum level of GDF15a and myocardial infarction area and the
prediction effect of GDF15a on myocardial infarction area.
Methods: 1. Experimental animals: 30 healthy Wistar rats, male, weighing 200w300
g, are selected. Rats are randomly divided into high ligation group, low ligation group
and sham operation group with 10 rats in each group. 2. Myocardial infarction model
set up: Rats are injected with 10% chloral hydrate and ﬁxed on the operation board,
assisted respiration with endotracheal intubation, connected to electrocardiograph
(ECG) and monitored. In high ligation group, the coronary arteries of rats are ligated
about 3mm from the aortic root which is between the left atrial and pulmonary arterial
cone. In low ligation group, the coronary arteries are ligated about 2 mm from the tip
of left atrial appendage. Method used in sham operation group is similar to low
ligation group but without coronary artery ligation. Penicillin is applied in order to
prevent postoperative infection. 3. Rats serum GDFl5a detection: 2ml blood sample is
taken from the abdominal aorta of each rat in 24h after operation, GDFl5a is then
detected using ELISA method. 4. Infarction area computation: Each rat is sacriﬁced
after blood sampling, heart is harvested, the left ventricular long axis transverse
segment which is below the left coronary artery ligation point is collected and
sectioned, the thickness of the slices is 4mm. The slices are then HE stained and used
to do heart-pathological monitoring and compute infarction area. Infarction area (%)¼
[(The endocardial length of the left ventricular infarct / Total endocardial circumfer-
ence) /2 + (The epicardial length of the left ventricular infarct / Total epicardial
circumference) /2] 100%. Calculation is implemented by the professional image
analysis software IPP 6.0. 5. Statistical method: Measurement results are showed in
the manner of averagestandard deviation (SD), ANOVA and t test are applied to
calculate statistical signiﬁcance, all analysis are done using statistical software
SPSS 17.0.
Results: Three rats in high ligation group are dead in 24h after operation compared to
one rat in low ligation group. Result 1: Serum GDFL5a detection results for each
group: the contents of GDFL5a are respectively 1190.261.4ng/L in high ligation
group, 931.693.0ng/L in low ligation group and 637.261.2ng/L in sham operation
group. ANOVA result for the average comparison of three groups is F¼117.8 with
P<0.001, which shows that this result has statistical meaning and the content of
GDFl5a in high ligation group is signiﬁcantly higher than the ones in low ligation
group and sham operation group. Result 2: Computation of infarction area between
three groups: The infarction areas are respectively 57.74.0 in high ligation group,
38.64.6 in low ligation group and 0 in sham operation group. T-test is applied to
compare the areas between high ligation group and low ligation group, t¼8.7 withJACC Vol 64/16/Suppl C j October 16–19, 2014 j GW-ICC Abstracts/BP<0.001, which shows that this result also has statistical meaning and infarction area
in high ligation group is signiﬁcantly larger than the one in low ligation group.
Conclusions: The serum level of GDFl5a rises for the rats with cardiac obstruction, its
level rises with an increasing infarction area, this phenomenon shows that the serum
level of the GDFl5a has certain prediction effect on the infarction area.
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Magnolol administration in prehypertension postpones the development of
hypertension and the underlying mechanisms
Xiangyan Liang1, Wenjuan Xing2, Jinxiao He3, Fange Liu1, Feng Gao2,
Haifeng Zhang1
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Objectives: Patients with prehypertension are more likely to progress to manifest
hypertension than those with optimal or normal blood pressure. However, the
mechanisms underlying the development from prehypertension to hypertension still
remain largely elusive and the drugs for antihypertensive treatment in prehypertension
are absent. Here we determined the effects of magnolol (MAG) on blood pressure and
aortic vasodilatation to insulin, and investigated the underlying mechanisms.
Methods: Four-week-old male spontaneous hypertensive rats (SHR) and age-matched
normotensive Wistar-Kyoto (WKY) control rats weretreated with vehicle (distilled
water) or MAG (100 mg/kg/day, o.g., once daily) for 3 weeks. Additionally, human
umbilical vein endothelial cells (HUVECs) were exposed to glucose (25 mmol/L) and
saturated FFA palmitate (16:0; 500 mmol/L) (HG/HF) for 18 hours and treated with
MAG (10mmol/L) for 48 hours.
Results: MAG signiﬁcantly decreased blood pressure in seven-week-old SHR (SBP:
1316 vs. 16011 mmHg in vehicle-treated SHR, DBP: 1065 vs. 1278 mmHg,
n¼8, P<0.01), improved insulin-induced aorta vasodilation (relaxation: 57.4%2.4%
vs. 42.2%5.3%, n¼6, P<0.01), restored Akt and eNOS phosphorylations stimulated
by insulin, and increased PPARg and decreased TRB3 expressions (n¼5-6, P<0.05).
Furthermore, in cultured HUVECs, MAG incubation increased PPARg, decreased
TRB3 expressions, and restored insulin-induced phosphorylated Akt and eNOS levels
and NO production (P<0.05), which was blocked by both PPARg antagonist and
siRNA targeting PPARg (P<0.05).
Conclusions: Treatment of young SHRs with MAG beginning at the prehypertensive
stage decreases blood pressure via improving vascular insulin resistance, which is at
least partly attributable to upregulated PPARg, downregulated TRB3 and conse-
quently increased Akt and eNOS activations in blood vessels. These results indicate
that MAG may be used as an antihypertensive drug early administrated at the pre-
hypertensive stage.
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Genotype-phenotype analysis on a large cohort of Chinese LQTS patients
Gao Yuanfeng1, Wenling Liu1, Li Zhang2, Dayi Hu1, Cuilan Li1
1Heart Center, Peking University People’s Hospital, Beijing, 100044, P.R.China,
2Lankenau Medical Center, Lankenau Institute for Medical Research, Jefferson
Medical College, Philadelphia, PA, U.S.A.
Objectives: Long QT syndrome (LQTS) is an inherited cardiac disorder characterized
by syncope or even sudden death. Although a variety of clinical index could point to a
diagnosis of LQTS, gene-screening remains to be the golden standard for LQTS
diagnosis. In addition, while 15 genes have been identiﬁed as LQTS causing
genes, 90% of the mutationslie mainly in KCNQ1, KCNH2, SCN5A– the causing
genes of LQT1-3. So, in the present study, we aim to evaluate the diagnostic value of
the clinical data by analyzing the genetically diagnosed LQTS patients. Besides, we
also investigated the mutation spectrum and gene distribution of Chinese LQTS
patients.
Methods: 214 LQTS patients, selected from the Chinese Channelopathy Registry
Study, were enrolled into this study. Patients were evaluatedbased on QTcandclinical
manifestations. Individuals were clinically diagnosed as LQTS if presenting a pro-
longed QT interval (QTc450ms for male; QTc470ms for female) and/or docu-
mented TdP (Torsade de Pointes), ventricular ﬁbrillation as well as cardiac arrest.
Mutational screening of KCNQ1, KCNH2, SCN5A genes was performed by PCR
and direct DNA sequence analysis. LQTS phenotype were evaluated for all putative
LQTS patients.
Results: For the total cohort of the LQTS patients, 173 patients were genotype-pos-
itive for LQTS, while 41 negative. We compared the phenotypes between the two
groups. Statistical results indicate that differences of average QTc, Schwartz score,-
percentages of patients with syncope, and Schwartz score>4 between the two groups
are signiﬁcant (P<0.05), while those of age of ﬁrst syncope, gender (female vs. male),
percentages of patients with QTc>480ms and TdP not (P>0.05).
Overall, 173 of 214 (81%) LQTS patients were found to harbor at least one putative
LQTS-causing mutation. Among them, 99 mutations were identiﬁed: 42 were in
KCNQ1, 54 in KCNH2, 3 in SCN5A. In this set of mutations, 42 were novel, including
15 in KCNQ1, 27 in KCNH2, and none in SCN5A. To be speciﬁc, most of mutations
(71 of 99, 72%) were missense, while frame-shift mutations, splice sites, nonsense and
inframe deletions account for 15% (15/99), 5% (5/99), 5% (5/99), 2% (2/99), respec-
tively.Most frameshift mutations (11 of 15, 73%) were found in KCNH2 (representing
20% of all KCNH2mutations), while 80% (4/5) of the splice mutations were identiﬁedasic and Translational Medicine C25
